Venture Capital Investors

Osage Partners

VC firm Osage Partners provides capital to innovative technology companies.

Venture Investor Overview

Venture Investor
Osage Partners
Status
InActive
Investor Type
Venture Capital
Activity Level
185 transactions
Funds Raised
At least $871.9 million
Industry Focus
Blockchain
Clean Tech
Medical Devices & Instruments
Security

Contact Information

Contact
Robert Adelson
Title
Managing Partner
Mailing Address
50 Monument Road 201
Bala Cynwyd, PA 19004
USA
Phone
(484) 434-2255
Website
www.osagepartners.com
Email Address
Not Recorded

Background Information

Overview
Osage Partners is a family of venture capital funds that includes Osage Venture Partners and Osage University Partners. Each fund has a dedicated professional staff and a distinct investment strategy.
Profile
Osage Partners LinkedIn Company Profile
Social Media
Osage Partners Company Twitter Account
Company News
Osage Partners News
Facebook
Osage Partners on Facebook
YouTube
Osage Partners on YouTube
Last Transaction
6/29/2022

Transaction History

Our records indicate that Osage Partners invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
Trinsic
6/29/2022
$8,500,000
MicroTransponder
6/20/2022
$53,000,000
Tellie
6/14/2022
$10,000,000
Brimstone Energy
4/28/2022
$55,000,000
Circonus
11/18/2021
$10,000,000
ReCode Therapeutics
10/23/2021
$80,000,000
Malbek
9/29/2021
$15,300,000
DeepHow
9/16/2021
$9,000,000
Vanqua Bio
9/15/2021
$85,000,000
DiCE Molecules
8/25/2021
$60,000,000
Sonoma Biotherapeutics
8/5/2021
$265,000,000
Glyphic Biotechnologies
7/28/2021
$6,025,000
Verve Motion
7/16/2021
$15,000,000
Ribon Therapeutics
7/15/2021
$65,000,000
Ostendio
6/17/2021
Unknown
Interius BioTherapeutics
5/19/2021
$76,000,000
Pliant
5/7/2021
$10,000,000
Strategikon Pharma
4/27/2021
Unknown
ExecOnline
4/22/2021
$45,000,000
Fortis Therapeutics
3/30/2021
$40,000,000
Connected2Fiber
3/23/2021
$12,000,000
Refraction AI
3/10/2021
$4,200,000
eGenesis
3/3/2021
$125,000,000
Cyteir Therapeutics
2/12/2021
$80,000,000
Neuros Medical
1/11/2021
$38,500,000
DiCE Molecules
1/11/2021
$80,000,000
Atsena Therapeutics
12/17/2020
$55,000,000
indico
12/15/2020
$22,000,000
boodleAI
12/10/2020
$3,500,000
MarginEdge
11/20/2020
$4,000,000
Palladio
9/28/2020
$20,000,000
Escient Pharmaceuticals
9/15/2020
$77,500,000
HelloTeam
8/19/2020
$3,500,000
SiFive
8/12/2020
$61,000,000
StreetLight Data
8/7/2020
$15,000,000
Aerovate Therapeutics
8/7/2020
$72,600,000
Vor Biopharma
7/8/2020
$110,000,000
Malbek
5/14/2020
$3,000,000
ReCode Therapeutics
3/27/2020
$80,000,000
Circonus
1/22/2020
$6,800,000
MarginEdge
10/23/2019
$5,000,000
IonQ
10/23/2019
$55,000,000
ArsenalBio
10/18/2019
$85,000,000
Cyteir Therapeutics
10/16/2019
$40,200,000
Earnest Research
9/11/2019
$15,000,000
Landos Biopharma
8/14/2019
$60,000,000
Cleave Therapeutics
8/8/2019
$12,000,000
Connected2Fiber
7/31/2019
$5,300,000
Menlo Security
7/10/2019
$75,000,000
Everactive
6/20/2019
$30,000,000
SiFive
6/10/2019
$65,400,000
Algorithmia
5/16/2019
$25,000,000
Twentyeight-Seven Therapeutics
5/10/2019
$15,000,000
LunaPBC
5/9/2019
$4,600,000
Satsuma Pharmaceuticals
4/26/2019
$62,000,000
Arrakis Therapeutics
4/19/2019
$75,000,000
RiskLens
4/9/2019
$20,550,000
Vor Biopharma
2/15/2019
$42,000,000
KenSci
2/8/2019
$22,000,000
Ribon Therapeutics
1/7/2019
$65,000,000
Elementary Robotics
12/20/2018
$3,600,000
ExecOnline
10/3/2018
$18,000,000
Modis Therapeutics
10/2/2018
$30,000,000
DrayNow
8/29/2018
$5,000,000
StreetLight Data
8/8/2018
$10,000,000
Antiva Biosciences
7/12/2018
$15,000,000
Precision BioSciences
6/27/2018
$110,000,000
Embodied
6/19/2018
$22,000,000
Escient Pharmaceuticals
5/10/2018
$40,000,000
Synthorx
5/1/2018
$63,000,000
NuMat Technologies
4/27/2018
$12,400,000
SiFive
4/3/2018
$50,600,000
CounterFlow
3/1/2018
$2,700,000
indico
1/19/2018
$4,000,000
Connected2Fiber
1/17/2018
$8,000,000
HelloTeam
1/12/2018
$2,700,000
Aptinyx
12/19/2017
$70,000,000
Pionyr Immunotherapeutics
12/14/2017
$62,000,000
Menlo Security
12/12/2017
$40,000,000
Noodle Partners
12/5/2017
$14,000,000
Quantum Circuits
11/15/2017
$18,000,000
Hive-IO
10/11/2017
Unknown
VividCortex
8/16/2017
$8,500,000
Neuros Medical
8/8/2017
$20,000,000
ExecOnline
7/29/2017
$16,000,000
Corelight
7/19/2017
$9,200,000
E-Scape Bio
7/13/2017
$63,000,000
Lastline
7/12/2017
$28,500,000
RiskLens
7/12/2017
$5,000,000
Algorithmia
6/26/2017
$10,500,000
Hyalex Orthopaedics
6/1/2017
$16,000,000
Sidecar
5/12/2017
$11,000,000
SiFive
5/9/2017
$8,500,000
Antiva Biosciences
3/29/2017
$22,000,000
Arrakis Therapeutics
2/28/2017
$38,000,000
PMV Pharmaceuticals
2/23/2017
$74,000,000
KenSci
1/27/2017
$8,500,000
Pionyr Immunotherapeutics
1/5/2017
$8,000,000
Biohaven Pharmaceuticals
11/2/2016
$80,000,000
Clarifai
10/26/2016
$30,000,000
Fortis Therapeutics
9/28/2016
$18,000,000
RackWare
9/14/2016
$10,000,000
Iconic Therapeutics
8/10/2016
$10,000,000
Cleave Biosciences
8/9/2016
$37,000,000
Blade Therapeutics
6/20/2016
$45,000,000
Aptinyx
5/11/2016
$65,000,000
Kymeta
1/11/2016
$62,000,000
Iconic Therapeutics
1/11/2016
$40,000,000
Millendo Therapeutics
1/4/2016
$62,000,000
Enlibrium
12/4/2015
$15,000,000
Everactive
11/3/2015
$16,350,185
OpsDataStore
10/28/2015
$3,000,000
SevOne
9/24/2015
$50,000,000
Body Labs
9/11/2015
$8,000,000
Selecta Biosciences
9/8/2015
$38,000,000
Brazen
6/25/2015
$4,700,000
Pneuron
6/12/2015
$5,067,377
Menlo Security
6/8/2015
$25,000,000
Mirna Therapeutics
4/30/2015
$41,800,000
Clarifai
4/29/2015
$10,000,000
ResiModel
4/23/2015
$900,000
Paracosm
3/31/2015
$812,000
Collections Marketing Center
3/31/2015
$7,600,000
Merganser Biotech
2/19/2015
$28,000,000
Jibo
1/21/2015
$25,300,000
Canvas
12/10/2014
$9,000,000
PMV Pharmaceuticals
12/3/2014
$30,000,000
Menlo Security
11/19/2014
$10,500,000
Paracosm
11/5/2014
$3,300,000
Liquid Light
9/11/2014
$15,000,000
RackWare
7/9/2014
$2,300,000
Automated Insights
6/30/2014
$5,500,000
Sidecar
6/5/2014
$3,100,000
Otonomy
4/30/2014
$49,000,000
Everactive
3/31/2014
$5,963,000
Kolltan Pharmaceuticals
3/20/2014
$60,000,000
Infinio
12/16/2013
$12,000,000
Immune Design
10/30/2013
$49,000,000
Sideris Pharmaceuticals
10/23/2013
$32,000,000
Otonomy
9/4/2013
Unknown
Evolv Technology
9/2/2013
$11,820,000
Kymeta
7/9/2013
$50,000,000
Medallion Analytics Software
6/30/2013
$1,250,000
RackWare
6/27/2013
$3,000,000
Canvas
6/3/2013
$4,000,000
eFFECTOR Therapeutics
5/21/2013
$45,000,000
Skytree
4/30/2013
$18,000,000
Millendo Therapeutics
3/31/2013
$5,017,000
BA Insight
3/26/2013
$4,500,000
PeopleLinx
3/18/2013
$3,200,000
Pneuron
3/6/2013
$6,000,000
AGTC
11/21/2012
$37,500,000
Cardioxyl Pharmaceuticals
11/7/2012
$28,050,000
Mirna Therapeutics
10/24/2012
$34,500,000
Ceptaris Therapeutics
6/5/2012
$10,000,000
SolarBridge Technologies
5/30/2012
$25,000,000
Carnegie Speech
5/17/2012
$3,400,000
Halfpenny Technologies
2/22/2012
$2,250,000
Identropy
1/17/2012
$4,000,000
Sera Prognostics
11/15/2011
$19,300,000
Tangent Medical Technologies
11/3/2011
$4,500,000
MC10
6/28/2011
$12,500,000
FieldView Solutions
6/15/2011
$2,000,000
Collections Marketing Center
5/9/2011
Unknown
Halfpenny Technologies
10/8/2010
$2,600,000
InstaMed
9/30/2010
$6,000,000
BA Insight
9/20/2010
$6,000,000
InstaMed
6/30/2010
Unknown
Gevo
6/30/2010
$16,150,200
CampaignerCRM
6/30/2010
Unknown
FieldView Solutions
12/17/2009
$2,750,000
Virdante Pharmaceuticals
10/29/2009
$47,750,000
Corridor Pharmaceuticals
10/2/2009
$10,750,000
Ceptaris Therapeutics
9/30/2009
$3,140,000
Melior Discovery
9/30/2009
$825,000
ProtonMedia
7/15/2009
$2,500,000
SevOne
6/30/2009
$2,000,000
InstaMed
3/18/2009
$6,000,000
Hardmetrics
3/31/2008
$1,247,000
Carnegie Speech
11/12/2007
$6,000,000
SevOne
9/4/2007
$1,500,000
Hardmetrics
12/5/2006
$4,000,000
Ceptaris Therapeutics
11/13/2006
$4,000,000
CampaignerCRM
6/30/2006
$3,000,000
Melior Discovery
3/31/2006
$3,700,000

 

Investor Contacts

Title
Name
Email & Social
Managing Partner
Robert Adelson
  Robert Adelson LinkedIn Profile  Robert Adelson Twitter Account  Robert Adelson News  Robert Adelson on Facebook
Partner
David Drahms
  David Drahms LinkedIn Profile  David Drahms Twitter Account  David Drahms News  David Drahms on Facebook
Managing Partner
Nathanael Lentz
  Nathanael Lentz LinkedIn Profile  Nathanael Lentz Twitter Account  Nathanael Lentz News  Nathanael Lentz on Facebook
Managing Partner
Marc Singer
  Marc Singer LinkedIn Profile  Marc Singer Twitter Account  Marc Singer News  Marc Singer on Facebook

 

Funds

Our database includes the following fund closing(s) for Osage Partners. If we are missing funds, please contact us.

Fund Description
Vintage Date
Fund Amount
Osage University Partners III
3/12/2019
$273,000,000
Fund 9
5/23/2017
$90,000,000
Osage Venture Partners IV
11/6/2015
$87,900,000
Osage University Partners II
5/21/2015
$215,000,000
Osage Venture Partners III
8/22/2012
$66,000,000
Osage University Partners I
2/24/2011
$100,000,000
Osage Venture Partners II
6/30/2005
$40,000,000

 

Portfolio Companies

Osage Partners has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
Aerovate Therapeutics
AGTC
Algorithmia
Antiva Biosciences
Aptinyx
Arrakis Therapeutics
ArsenalBio
Atsena Therapeutics
Automated Insights
BA Insight
Biohaven Pharmaceuticals
Blade Therapeutics
Body Labs
boodleAI
Brazen
Brimstone Energy
CampaignerCRM
Canvas
Cardioxyl Pharmaceuticals
Carnegie Speech
Ceptaris Therapeutics
Circonus
Clarifai
Cleave Biosciences
Cleave Therapeutics
Collections Marketing Center
Connected2Fiber
Corelight
Corridor Pharmaceuticals
CounterFlow
Cyteir Therapeutics
DeepHow
DiCE Molecules
DrayNow
E-Scape Bio
Earnest Research
eFFECTOR Therapeutics
eGenesis
Elementary Robotics
Embodied
Enlibrium
Escient Pharmaceuticals
Everactive
Evolv Technology
ExecOnline
FieldView Solutions
Fortis Therapeutics
Gevo
Glyphic Biotechnologies
Halfpenny Technologies
Hardmetrics
HelloTeam
Hive-IO
Hyalex Orthopaedics
Iconic Therapeutics
Identropy
Immune Design
indico
Infinio
InstaMed
Interius BioTherapeutics
IonQ
Jibo
KenSci
Kolltan Pharmaceuticals
Kymeta
Landos Biopharma
Lastline
Liquid Light
LunaPBC
Malbek
MarginEdge
MC10
Medallion Analytics Software
Melior Discovery
Menlo Security
Merganser Biotech
MicroTransponder
Millendo Therapeutics
Mirna Therapeutics
Modis Therapeutics
Neuros Medical
Noodle Partners
NuMat Technologies
OpsDataStore
Ostendio
Otonomy
Palladio
Paracosm
PeopleLinx
Pionyr Immunotherapeutics
Pliant
PMV Pharmaceuticals
Pneuron
Precision BioSciences
ProtonMedia
Quantum Circuits
RackWare
ReCode Therapeutics
Refraction AI
ResiModel
Ribon Therapeutics
RiskLens
Satsuma Pharmaceuticals
Selecta Biosciences
Sera Prognostics
SevOne
Sidecar
Sideris Pharmaceuticals
SiFive
Skytree
SolarBridge Technologies
Sonoma Biotherapeutics
Strategikon Pharma
StreetLight Data
Synthorx
Tangent Medical Technologies
Tellie
Trinsic
Twentyeight-Seven Therapeutics
Vanqua Bio
Verve Motion
Virdante Pharmaceuticals
VividCortex
Vor Biopharma

 

 

 

 

Browse more venture capital investors:

OS Fund | Osage University Partners

 

Share this article

 

About Our Venture Capital Investor Database

This VC firm profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.